Form 4 for TNYA Tenaya Therapeutics, Inc.
Accepted 2026-05-19 19:06:46 ET · period of report 2026-05-18 · accession 0001193125-26-231315 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 19:06 | 2026-05-18 | TNYA | Higa Tomohiro | SVP, Fin | S - Sale | $0.7932 | -1,485 | 118.3K | -1% | -$1,178 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | S | D | 1,485 | $0.7932 | 118,267 | D | — | — | (F1) Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on August 15, 2024. (F2) Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |